Trial · NCT07894822
Single-Session Microfocused Ultrasound, AbobotulinumtoxinA and Temporal Hyaluronic Acid Filler for Non-Surgical Brow Lifting
NCT07894822, Completed, Estelab Clinic
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Single-Session Microfocused Ultrasound, AbobotulinumtoxinA and Temporal Hyaluronic Acid Filler for Non-Surgical Brow Lifting. Trials, record NCT07894822. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07894822
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Single-Session Microfocused Ultrasound, AbobotulinumtoxinA and Temporal Hyaluronic Acid Filler for Non-Surgical Brow Lifting
- NCT number
- NCT07894822
- Status
- Completed
- Enrollment
- 36 participants, actual
- Lead sponsor
- Estelab Clinic
- Conditions
- Brow Ptosis, Skin Aging, Facial Aging
- Interventions
- Microfocused ultrasound with visualization, AbobotulinumtoxinA, Hyaluronic acid filler
- First posted
- 2026-10-26
- Last updated
- 2026-10-26
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change From Baseline in Mean Eyebrow Height | Baseline, immediately after treatment, and 1, 3, 6, and 12 months after treatment | Mean of six standardized distances (mm) from the line through the medial canthi to the upper edge of the eyebrow, measured on standardized photographs by two blinded dermatologists; right and left values averaged. |
| Primary | Change From Baseline in Maximum Eyebrow Height | Baseline, immediately after treatment, and 1, 3, 6, and 12 months after treatment | Largest of six standardized distances (mm) from the line through the medial canthi to the upper edge of the eyebrow, measured on standardized photographs by two blinded dermatologists; right and left values averaged. |
| Primary | Number of Participants With Adverse Events | From treatment to 12 months | Adverse events identified by clinical examination at each visit, including type, severity, and duration. |
| Secondary | Global Aesthetic Improvement Scale (GAIS) Score | Immediately after treatment and 1, 3, 6, and 12 months after treatment | Five-point scale (1 = very much improved, 2 = much improved, 3 = improved, 4 = no change, 5 = worse), rated separately by an independent blinded physician and by the participant. |
| Secondary | FACE-Q Satisfaction With Upper Eyelids Score | Baseline and 12 months after treatment | Patient-reported FACE-Q Eye Module scale, Rasch-transformed score from 0 (worst) to 100 (best). |
| Secondary | Procedural Pain | During the procedure (day 0) | Pain during microfocused ultrasound rated on a 0-10 numeric rating scale (0 = no pain, 10 = worst imaginable pain). |
| Other | Change in Eyebrow Height According to Facial Aging Type | Baseline to 12 months after treatment | Exploratory comparison of changes in mean and maximum eyebrow height (mm) between facial aging types. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07894822
GET https://conductscience.org/api/trials/v1/NCT07894822/registered